INTRODUCTION
============

With the disseminated use of imaging methods for the investigation of abdominal diseases, the identification of incidental findings whose management is not always easy or consensual has become increasingly common. Complex renal cysts are fully representative of such a situation.

In 1986 Morton Bosniak published a review article in which he suggested a classification and further management of cystic lesions of the kidneys based on findings on contrast-enhanced computed tomography (CT)^([@r01])^. The classification was gradually adopted by imaging specialists and urologists, and is currently a reference in the field ([Figure 1](#f01){ref-type="fig"}).

![Illustration demonstrates the main findings in the Bosniak classification for renal cystic lesions. **A:** Category I. **B** and **C:** Category II, hyperdense on B. **D:** Category IIF. **E:** Category III. **F:** Category IV.](rb-47-06-0368-g01){#f01}

However, in spite of the standardized description that was suggested by Bosniak, there remained a subjective component to the assessment of these lesions, in particular for distinguishing between minimally complex and benign lesions (Bosniak II) whose surgical approach is not mandatory, or complex and possibly malignant cysts (Bosniak III), for which surgical approach is recommended^([@r02]-[@r05])^. In order to address this problem, a few years later Bosniak and his collaborators suggested the introduction of a fifth category, called II-F (\"F\" as follow-up), in his classification^([@r06]-[@r08])^. The classification would undergo another small change in 2005^([@r09])^, reaching its current format^([@r10])^, which is shown in [Table 1](#t01){ref-type="table"}. According to the current classification, lesions in category I correspond to simple cysts without septa or vegetations, with thin and smooth walls, and no contrast enhancement after the administration of intravenous contrast agents ([Figure 2A](#f02){ref-type="fig"}). Category II includes cysts with thin septations, minimally thick walls and fine parietal calcifications, and no contrast enhancement after intravenous contrast agent injection ([Figure 2A](#f02){ref-type="fig"}). Homogeneous hyperdense cysts ≤ 3.0 cm are included in this category. Lesions with irregular and/or thick septa, with course calcifications, and clear enhancement after intravenous contrast injection are described as category III ([Figure 2B](#f02){ref-type="fig"}). Category IV is reserved for lesions with septa or walls with well-defined solid components that demonstrate contrast-enhancement after intravenous contrast injection ([Figure 2C](#f02){ref-type="fig"}). Category II-F corresponds to indeterminate lesions with findings described on [Table 1](#t01){ref-type="table"}, which, although not sufficient to indicate surgical exploration, suggest a slight risk of malignancy ([Figure 3](#f03){ref-type="fig"}).

![**A:** Categories I and II. Contrast-enhanced, axial CT section demonstrates a cyst with smooth and imperceptible walls, category I, and another with fine calcifications on its walls (arrow), category II, both without perceptible contrast-enhancement. **B:** Category III. Contrast-enhanced axial CT section demonstrates a cyst with smooth walls and a thin septum with perceptible and measurable enhancement after intravenous contrast injection (arrow). **C:** Category IV. Contrast-enhanced axial CT section demonstrates a mixed, thick-walled cystic-solid lesion with a solid component in the posterior wall (asterisk) that shows homogeneous enhancement after intravenous contrast injection.](rb-47-06-0368-g02){#f02}

![Bosniak II-F cyst. Contrast-enhanced CT image shows a partially exophytic cyst with a fine septation inside. Subtle nodularity is observed in the septum, which has perceptible but not measurable contrast-enhancement (arrow).](rb-47-06-0368-g03){#f03}

###### 

Imaging findings and Bosniak classification (adapted from references 1, 5, 6 and 9).

  Type                                                                             Imaging features without contrast                                                                                                                                   Contrast enhancement features
  -------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------
  I                                                                                Water density (0--20 HU), thin margins, sharp delineation with the renal parenchyma, thin and smooth walls, homogeneous                                             No contrast enhancement
  II                                                                               Presence of one or few thin septations, small and fine calcifications; hyperdense cysts measuring up to 3.0 cm (60--70 HU)                                          No contrast enhancement, or no measurable or perceptible enhancement of septa
  IIF                                                                              More complex lesions which cannot be included in category II or III. Multiple septa. Walls or septa with nodular or irregular calcifications                        Absent, dubious or hair-like enhancement
  Hyperdense cysts \> 3.0 cm or with only 25% of their walls visible (exophytic)                                                                                                                                                                       
  III                                                                              Thick-walled cystic lesion, septum irregularity and heterogeneous septum and wall and/or contents. Gross and irregular calcifications with measurable enhancement   Wall or septum enhancement
  IV                                                                               Lesions with all the findings of category III, and solid component, soft parts, independent of finding of wall or septa                                             Enhancement of wall and/or solid component(s)

VALIDATION AND CONTROVERSIES
============================

Several studies, most retrospective, have evaluated the effectiveness of the Bosniak classification^([@r11]-[@r15])^. A recent metaanalysis that included nine studies with at least 30 cases each^([@r16])^ showed that the inclusion of the category II-F led to a reduction of the number of cases included in category III and, consequently, to a decrease in the number of surgical exploration of benign lesions. The negative predictive value of categories I and II remained the same^([@r16])^. The percentage of malignant lesions in category I was 0%, 15.6% for category II, 0% for category II-F, 65.3% for category III, and 91.7% for category IV. The high frequency of malignant lesions in category II was driven by a single study in which two lesions were classified as Bosniak II and one was malignant^([@r11])^. In another recent study, patients with cysts classified as II-F and III were followed either until proved stable or submitted to surgical resection^([@r17])^. The frequency of malignant lesions was 25% and 54% for categories II-F and III, respectively. The authors have also observed that previous history of malignant renal neoplasia, and coexistence of malignant solid lesion, Bosniak category IV, or multiple Bosniak III cysts represent risk factors and increase the proportion of malignant lesions in cysts category III. Except for one study, the review of the most relevant articles (n \> 30 patients) published until 2012 ([Table 2](#t02){ref-type="table"}) shows that one should expect a very low frequency of malignancy in category II-F.

###### 

Frequency of malignancy in cystic lesions, stratified by Bosniak classification; studies with more than 30 patients.

  Study                        Bosniak category                          
  ---------------------------- ------------------ ------ ------ -------- -------
  Siegel et al.^([@r18])^      0/22               1/8    ---    5/11     26/29
  Koga et al.^([@r11])^        0/11               1/2    ---    10/10    12/12
  Israel et al.^([@r19])^      ---                ---    0/39   2/3      ---
  O\'Malley et al.^([@r20])^   ---                ---    0/81   27/33    ---
  Song et al.^([@r15])^        0/3                3/26   0/3    21/38    32/37
  Smith et al.^([@r17])^       ---                ---    4/16   58/107   ---

The introduction of category II-F has allowed for a more systematic approach to distinguish between categories II and III; however, there remains room for improvements, as findings that define a cyst as II-F are not always clearly noticeable. For example, in addition to being tenuous, the identification of enhancement in hair-like septa is subjective ([Figure 3](#f03){ref-type="fig"}). It is widely known that experience and, mainly, the correlation with surgical exploration and histopathological findings improve the individual performance in the utilization of the Bosniak classification.

The Bosniak classification suggests the necessity of follow-up of lesions classified as II-F, but it does neither establish an interval for imaging repetition nor the total follow-up duration period. This has led to distinctive approaches reported in recent publications^([@r14],[@r15],[@r17])^. Bosniak himself recognizes the presence of heterogeneity among lesions in category II-F^([@r09])^, some of which have lower risk of malignancy and require short-term imaging follow-up every six months for a two-year period; and others with more suspicious findings that are likely to benefit from longer follow-up period (up to four years) before being reclassified as category II, if stable^([@r20]-[@r22])^. In the authors\' experience, more suspicious lesions might be followed-up during the first year at shorter intervals (three to four months), alternating ultrasonography (US) and contrast-enhanced enhanced cross-sectional imaging (CT and magnetic resonance imaging - MRI), and every six months thereafter ([Figure 4](#f04){ref-type="fig"}). In these instances, the observation of changes in the internal architecture of the complex cyst is equally or more important than the evaluation of its growth.

![Progression of a complex cystic lesion. **A:** Contrast-enhanced CT. Initial study shows a small hypodense cortical lesion in the upper pole of the left kidney (arrow). **B:** Contrast-enhanced CT image acquired four months later. Despite the significant enlargement of the lesion (arrow), it was classified as Bosniak II-F. After another follow-up scan that demonstrated further increase in dimensions, the lesion was resected and a clear cell renal cell carcinoma was diagnosed.](rb-47-06-0368-g04){#f04}

UTILIZATION OF OTHER DIAGNOSTIC METHODS: MRI AND US
===================================================

MRI has been widely used in the evaluation of cystic lesions in kidneys and other organs, usually with better performance than CT. In a study published in 2004, Bosniak recognized that the method is appropriate for his classification^([@r23])^.

MRI better demonstrates the presence of thin septa in cystic lesions, in particular within cysts \< 2.0 cm). Yet, because of artifacts inherent to MR imaging, septa in renal cystic lesions may appear thicker than on CT ([Figure 5](#f05){ref-type="fig"}). This may lead to disagreements, and lesions classified as II or II-F on CT might be classified as II-F or III on MRI^([@r24])^. Additionally, less experienced observers tend to classify a higher number of lesions as II-F and III probably because of to the higher tissue and contrast resolution provided by MRI, possibly leading to a higher number of surgical explorations of benign lesions^([@r22])^.

![Evaluation of contrast enhancement at CT and MRI. **A:** Pre- and post-contrast, axial CT sections shows complex cyst with irregular walls and gross, parietal calcifications in the central region of the lesion. No defined enhancement is observed within the lesion. **B:** Post-gadolinium axial T1-weighted image with subtraction technique. Observe the nodular, irregular enhancement (arrow) adjacent to the calcifications. The lesion was reclassified as Bosniak IV and confirmed to be malignant.](rb-47-06-0368-g05){#f05}

The enhancement of thin septa, described as capillary or hair-like enhancement, is much more conspicuous at MRI than at CT, providing greater confidence in their detection and for denying the absence of contrast-enhancement. This fact, however, is unlikely to change management the vast majority of lesions will be classified within category II, rather than I. Other advantage of MRI is the identification of contrast-enhancement of internal septa within hemorrhagic cysts^([@r25])^. The high density of blood hinders the perception of contrast enhancement on CT, but subtraction techniques on MR imaging can bypass this situation ([Figure 5](#f05){ref-type="fig"}).

The use of ultrasound (US) in the Bosniak classification has never been unquestionably accepted, as the detection of neovascularization in malignant lesions, indicated by contrast enhancement of solid components, septa or walls, is a fundamental part of the classification^([@r26],[@r27])^. However, it is known that US may demonstrate internal septa better than CT and even MRI. Accordingly, it has been suggested that simple (Bosniak I) and minimally complex (Bosniak II) cysts may be followed with US only^([@r28])^.

Another potential advantage of US is its capacity of defining the cystic or solid nature of the lesion. In some situations, the characterization of remarkably hypovascular lesions may be difficult on CT ([Figure 6](#f06){ref-type="fig"}). The papillary renal cell carcinoma is an example of such tumors^([@r29])^ and its diagnosis may be difficult if the change in density between pre- and post-contrast phases approaches pseudoenhancement values (around 20 HU at 64-channel MDCT, and 10 HU at 16-channel MDCT)^([@r30])^. In addition to their hypovascular nature, papillary tumors present cystic degeneration with a frequency similar to the clear cell variant.

![Value of ultrasonography. **A,B:** Axial CT sections shows homogeneously hypodense, exophytic, circumscribed lesion (asterisks) in the middle third of the left kidney, with questionable contrast enhancement (18 HU difference). **C:** Cross sectional US clearly demonstrates a solid lesion (asterisk) with some areas of sound beam attenuation. Papillary carcinoma was confirmed after surgical resection.](rb-47-06-0368-g06){#f06}

Although not used to classify renal cystic lesions according to the Bosniak criteria, US can accurately indicate their degree of complexity and is an excellent method for the initial evaluation of patients with renal cystic lesions ([Figure 7](#f07){ref-type="fig"}).

![Ultrasonography. **A:** Sonographic section of the left kidney shows a cystic lesion with multiple septa inside, one of them with signal on color Doppler study (arrow). **B:** Contrast-enhanced axial MDCT section shows irregular septal enhancement. While not used to categorize lesions according to the Bosniak classification, the findings on US triggered further investigating and the lesion was confirmed to be a clear cell carcinoma.](rb-47-06-0368-g07){#f07}

NEW PROSPECTS
=============

Recent studies have demonstrated that the use of intravenous sonographic contrast agent may allow for the detection of enhancement in complex cystic lesions, even in cases of very thin septa (hair-like enhancement), with an accuracy superior to CT^([@r31])^. Limitations of such a technique include low reproducibility of the method, US operator dependence, and the cost of the contrast agent four times higher than the value of the iodinated contrast agent, a difference that might increase in cases of multiple cysts requiring repeated contrast injections.

Other techniques have been employed in an attempt to improve the characterization of complex renal cystic lesions. Among them, diffusion-weighted MRI has attracted more attention. The method allows for indirect evaluation of the cellularity of neoplasms, and in complex cystic lesions, restricted diffusion in solid components was shown to have a high positive predictive value for cancer^([@r32],[@r33])^ ([Figure 8](#f08){ref-type="fig"}).

![MRI and diffusion-weighted imaging (DWI). **A:** Axial T2-weighted image shows the presence of septa and solid contents on the anterior wall of the lesion (arrow). **B,C:** DWI and ADC mapping of the same lesion shows areas of water motion restriction identified as foci of high signal intensity at DWI and low signal on the ADC map (arrows). Note the significant difference favoring MRI in the characterization of complex cysts content. Clear cell renal cystic carcinoma was confirmed after resection](rb-47-06-0368-g08){#f08}

In summary, the Bosniak classification has allowed for the standardization of the description and management of renal cystic lesions. Initially described for CT, the classification is now used with some advantages with MRI. The introduction of the intermediate category II-F has created conditions to reduce the number benign lesions treated with surgery. Although not utilized to determine the Bosniak classification, ultrasound remains as an excellent method for detecting and defining the complexity of cystic lesions.
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